January 04, 2012
Abbott Laboratories on Tuesday dropped five consolidated patent infringement suits against Teva Pharmaceuticals Industries Ltd. over Teva's attempts to market a generic version of Abbott's cholesterol drug Simcor.
March 23, 2011
Abbott Laboratories launched another patent infringement suit in Delaware on Monday against generic-drug maker Teva Pharmaceutical Industries Ltd. in an effort to protect the market for cholesterol treatment Simcor.